Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Angell HK"'
Autor:
Berthe J; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Poudel P; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Segerer FJ; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Jennings EC; Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, United States., Ng F; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Surace M; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Andoni A; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Testori M; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Saraiya M; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Vuko M; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Hessel H; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Heininen-Brown M; Computational Pathology, Oncology R&D, AstraZeneca, Munich, Germany., Blando J; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States., Jones EV; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Willis SE; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Sorbonne Université, Université Paris Cité, Centre de Recherche des Cordeliers, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France., van de Ven R; Department of Otolaryngology, Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology Theme, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands., de Gruijl TD; Cancer Center Amsterdam, Cancer Biology and Immunology Theme, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands.; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Sep 20; Vol. 15, pp. 1422206. Date of Electronic Publication: 2024 Sep 20 (Print Publication: 2024).
Autor:
Secrier M; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.; UCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, London, United Kingdom., McGrath L; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Ng F; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gulati S; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Raymond A; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Nuttall BRB; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Berthe J; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jones EV; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Sidders BS; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.; Sorbonne Université, Université Paris Cité, Centre de Recherche des Cordeliers, Paris, France.; Equipe Labellisée Ligue Contre le Cancer, Paris, France., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Oct 20; Vol. 3 (10), pp. 2133-2145.
Autor:
Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK. Electronic address: matthew.krebs@manchester.ac.uk., Delord JP; Department of Medical Oncology, IUCT-Oncopole, Toulouse, France., Jeffry Evans TR; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., De Jonge M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kim SW; Asan Medical Center, Seoul, South Korea., Meurer M; Centre d'Essais Précoces en Cancérologie de Marseille, Assistance Publique-Hôpitaux de Marseille, Marseille, France., Postel-Vinay S; Department of Drug Development, Gustave Roussy Cancer Campus, Villejuif, France., Lee JS; Seoul National University College of Medicine, Bundang Hospital, Seoul, South Korea., Angell HK; AstraZeneca, Cambridge, UK., Rocher-Ros V; AstraZeneca, Cambridge, UK., Meyer K; AstraZeneca, Gaithersburg, MD, USA., Ah-See ML; AstraZeneca, Cambridge, UK., Herbolsheimer P; AstraZeneca, Gaithersburg, MD, USA., Lai Z; AstraZeneca, Gaithersburg, MD, USA., Nunes A; AstraZeneca, Gaithersburg, MD, USA., Domchek SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jun; Vol. 180, pp. 107216. Date of Electronic Publication: 2023 Apr 24.
Autor:
Willis SE; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Winkler C; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Roudier MP; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Baird T; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Marco-Casanova P; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Jones EV; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Rowe P; GMD, Oncology R&D, AstraZeneca, Macclesfield, UK., Rodriguez-Canales J; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Ng FSL; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Waring PM; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Hodgson D; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA., Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, UK., Weberpals JI; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Dean E; Clinical, Oncology R&D, AstraZeneca, Cambridge, UK., Harrington EA; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Pierce AJ; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Leo E; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK. gemma.jones@astrazeneca.com.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Dec; Vol. 125 (12), pp. 1666-1676. Date of Electronic Publication: 2021 Oct 18.
Autor:
Creelan BC; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB-1, Tampa, FL, 33612, USA. Ben.Creelan@moffitt.org., Yeh TC; Translational Medicine, Oncology R&D, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea., Nogami N; Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, 160 Minami-Umemoto-cho, Matsuyama City, 791-0280, Japan., Kim DW; Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Chow LQM; Department of Medicine, Division of Oncology, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, 98109, USA., Kanda S; Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, Nagano, 390-8621, Japan., Taylor R; Oncology, AstraZeneca, Academy House, 132-136 Hills Road, Cambridge, CB2 8PA, UK., Tang W; Clinical Pharmacology and Safety Assessment, AstraZeneca, One Medimmune Way, 101 ORD, 2001D, Gaithersburg, MD, 20878, USA., Tang M; Clinical Pharmacology and Safety Assessment, AstraZeneca, One Medimmune Way, 101 ORD, 2001D, Gaithersburg, MD, 20878, USA., Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Darwin Building, Unit 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK., Roudier MP; Translational Medicine, Oncology R&D, AstraZeneca, Darwin Building, Unit 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK., Marotti M; Oncology, AstraZeneca, Academy House, 132-136 Hills Road, Cambridge, CB2 8PA, UK., Gibbons DL; Departments of Thoracic/Head and Neck Medical Oncology and Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (2), pp. 383-390. Date of Electronic Publication: 2020 Oct 05.
Autor:
Bruni D; INSERM, Laboratory of Integrative Cancer Immunology; Équipe Labellisée Ligue Contre le Cancer; Sorbonne Université; Sorbonne Paris Cité; Université de Paris; Centre de Recherche des Cordeliers, Paris, France., Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Galon J; INSERM, Laboratory of Integrative Cancer Immunology; Équipe Labellisée Ligue Contre le Cancer; Sorbonne Université; Sorbonne Paris Cité; Université de Paris; Centre de Recherche des Cordeliers, Paris, France. jerome.galon@crc.jussieu.fr.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2020 Nov; Vol. 20 (11), pp. 662-680. Date of Electronic Publication: 2020 Aug 04.
Autor:
Domchek SM; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: susan.domchek@pennmedicine.upenn.edu., Postel-Vinay S; ATIP -Avenir group, Inserm Unit U981, Villejuif, France; Faculté de Médicine, Le Kremlin Bicêtre, Université Paris Saclay, Université Paris-Sud, Villejuif, France; Department of Drug Development, Gustave Roussy, Villejuif, France., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of South Korea., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea., Delord JP; Institut Universitaire du Cancer de Toulouse, Toulouse, France., Italiano A; Institut Bergonié, Bordeaux, France., Alexandre J; Hôpital Cochin, Paris, France., You B; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon, Centre d'Investigation de Therapeutiques en Oncologie et H ematologie de Lyon, Centre Hospitalier Lyon-Sud, Lyon, France; Faculté de Médecine Lyon-Sud, Univ Lyon, Université Claude Bernard Lyon 1, EMR UCBL/HCL 3738, Lyon, France; Groupe des Investigateurs Nationaux pour les Cancers de l Ovaire et du sein-GINEGEPS, Paris, France., Bastian S; Kantonsspital Graubuenden, Chur, Switzerland., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK; Manchester Academic Health Science Centre, Manchester, UK., Wang D; Henry Ford Medical Center, Detroit, MI, USA., Waqar SN; Washington University School of Medicine, Saint Louis, MO, USA., Lanasa M; AstraZeneca, Gaithersburg, MD, USA., Rhee J; AstraZeneca, Gaithersburg, MD, USA., Gao H; AstraZeneca, Cambridge, UK., Rocher-Ros V; AstraZeneca, Cambridge, UK., Jones EV; AstraZeneca, Cambridge, UK., Gulati S; AstraZeneca, Cambridge, UK., Coenen-Stass A; AstraZeneca, Cambridge, UK., Kozarewa I; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Gaithersburg, MD, USA., Angell HK; AstraZeneca, Cambridge, UK., Opincar L; AstraZeneca, Gaithersburg, MD, USA., Herbolsheimer P; AstraZeneca, Gaithersburg, MD, USA., Kaufman B; Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2020 Sep; Vol. 21 (9), pp. 1155-1164. Date of Electronic Publication: 2020 Aug 06.
Autor:
Angell HK; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, United Kingdom. helen.angell@astrazeneca.com., Bruni D; INSERM, Laboratory of Integrative Cancer Immunology, Équipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Paris, France., Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, Massachusetts., Herbst R; Department of Research, MedImmune, Gaithersburg, Maryland., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Équipe Labellisée Ligue Contre le Cancer, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, Paris, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 15; Vol. 26 (2), pp. 332-339. Date of Electronic Publication: 2019 Aug 14.
Autor:
Angell HK; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim KM; Department of Pathology & Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sharpe A; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Ogden J; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Davenport A; Wythenshawe Hospital, Manchester Foundation Trust., Hodgson DR; Oncology, IMED Biotech Unit, AstraZeneca, Macclesfield, UK., Barrett JC; Oncology, IMED Biotech Unit, AstraZeneca, Boston, USA., Kilgour E; Oncology, IMED Biotech Unit, AstraZeneca, Macclesfield, UK.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Dec 10; Vol. 8 (2), pp. e1544442. Date of Electronic Publication: 2018 Dec 10 (Print Publication: 2019).
Autor:
Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France. Electronic address: franck.pages@aphp.fr., Mlecnik B; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Inovarion, Paris, France., Marliot F; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Bindea G; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Ou FS; Cancer Center Statistics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Bifulco C; Department of Pathology, Providence Portland Medical Center, Portland, OR, USA., Lugli A; Institute of Pathology, University of Bern, Bern, Switzerland., Zlobec I; Institute of Pathology, University of Bern, Bern, Switzerland., Rau TT; Institute of Pathology, University of Bern, Bern, Switzerland., Berger MD; Department of Medical Oncology, University Hospital of Bern, Bern, Switzerland., Nagtegaal ID; Pathology Department, Radboud University, Nijmegen, Netherlands., Vink-Börger E; Pathology Department, Radboud University, Nijmegen, Netherlands., Hartmann A; Department of Pathology, University Erlangen-Nürnberg, Erlangen, Germany., Geppert C; Department of Pathology, University Erlangen-Nürnberg, Erlangen, Germany., Kolwelter J; Department of Pathology, University Erlangen-Nürnberg, Erlangen, Germany., Merkel S; Department of Surgery, University Erlangen-Nürnberg, Erlangen, Germany., Grützmann R; Department of Surgery, University Erlangen-Nürnberg, Erlangen, Germany., Van den Eynde M; Institut Roi Albert II, Department of Medical Oncology Cliniques Universitaires St-Luc, Brussels, Belgium; Institut de Recherche Clinique et Experimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium., Jouret-Mourin A; Department of Pathology, Cliniques Universitaires St-Luc, Brussels, Belgium; Institut de Recherche Clinique et Experimentale (Pole GAEN), Université Catholique de Louvain, Brussels, Belgium., Kartheuser A; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, Brussels, Belgium., Léonard D; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, Brussels, Belgium., Remue C; Institut Roi Albert II, Department of Digestive Surgery, Cliniques Universitaires St-Luc Université Catholique de Louvain, Brussels, Belgium., Wang JY; Curandis Laboratories, Boston, MA, USA; Department of Pathology and Laboratory Medicine, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Bavi P; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Roehrl MHA; Department of Pathology and Laboratory Medicine, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ohashi PS; University Health Network, Toronto, ON, Canada., Nguyen LT; University Health Network, Toronto, ON, Canada., Han S; University Health Network, Toronto, ON, Canada., MacGregor HL; University Health Network, Toronto, ON, Canada., Hafezi-Bakhtiari S; Department of Pathology and Laboratory Medicine, University Health Network, Toronto, ON, Canada., Wouters BG; University Health Network, Toronto, ON, Canada., Masucci GV; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, Stockholm, Sweden., Andersson EK; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University, Stockholm, Sweden., Zavadova E; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Vocka M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Spacek J; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Petruzelka L; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Konopasek B; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic., Dundr P; Institute of Pathology, First Faculty of Medicine, Charles University, Prague, Czech Republic; General University Hospital in Prague, Prague, Czech Republic., Skalova H; Institute of Pathology, First Faculty of Medicine, Charles University, Prague, Czech Republic; General University Hospital in Prague, Prague, Czech Republic., Nemejcova K; Institute of Pathology, First Faculty of Medicine, Charles University, Prague, Czech Republic; General University Hospital in Prague, Prague, Czech Republic., Botti G; Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, 'Fondazione G.Pascale' Naples, Italy., Tatangelo F; Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, 'Fondazione G.Pascale' Naples, Italy., Delrio P; Colorectal Surgery Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, 'Fondazione G.Pascale' Naples, Italy., Ciliberto G; IRCCS Istituto Nazionale Tumori 'Regina Elena', Rome, Italy., Maio M; Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy., Laghi L; Molecular Gastroenterology and Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy., Grizzi F; Molecular Gastroenterology and Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Humanitas University, Rozzano, Milan, Italy., Fredriksen T; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Buttard B; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Angelova M; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Vasaturo A; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Maby P; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Church SE; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; NanoString Technologies, Seattle, WA, USA., Angell HK; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Translational Science, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Lafontaine L; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., Bruni D; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France., El Sissy C; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Haicheur N; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Kirilovsky A; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Berger A; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Digestive Surgery Department, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Lagorce C; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France; Digestive Surgery Department, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France., Meyers JP; Cancer Center Statistics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Paustian C; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA., Feng Z; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA., Ballesteros-Merino C; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA., Dijkstra J; Pathology Department, Radboud University, Nijmegen, Netherlands., van de Water C; Pathology Department, Radboud University, Nijmegen, Netherlands., van Lent-van Vliet S; Pathology Department, Radboud University, Nijmegen, Netherlands., Knijn N; Pathology Department, Radboud University, Nijmegen, Netherlands., Mușină AM; University of Medicine and Pharmacy 'Grigore T. Popa' Iaşi, Department of Surgical Oncology, Regional Institute of Oncology, Iaşi, Roumania., Scripcariu DV; University of Medicine and Pharmacy 'Grigore T. Popa' Iaşi, Department of Surgical Oncology, Regional Institute of Oncology, Iaşi, Roumania., Popivanova B; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan., Xu M; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan., Fujita T; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan., Hazama S; Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Yamaguchi, Japan., Suzuki N; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Nagano H; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Okuno K; Department of Surgery, Kindai University, School of Medicine, Osaka-sayama, Japan., Torigoe T; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Sato N; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan., Furuhata T; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University School of Medicine, Sapporo, Japan., Takemasa I; Department of Surgery, Surgical Oncology, and Science, Sapporo Medical University School of Medicine, Sapporo, Japan., Itoh K; Department of Immunology and Immunotherapy, Kurume University School of Medicine, Kurume, Japan., Patel PS; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Vora HH; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Shah B; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Patel JB; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Rajvik KN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Pandya SJ; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Shukla SN; The Gujarat Cancer & Research Institute, Asarwa, Ahmedabad, India., Wang Y; Institute for Cancer Research of School of Basic Medical Science, Department of Pathology of the First Affiliated Hospital, Health Science Center of Xi'an Jiaotong University, Xian, China., Zhang G; Institute for Cancer Research of School of Basic Medical Science, Department of Pathology of the First Affiliated Hospital, Health Science Center of Xi'an Jiaotong University, Xian, China., Kawakami Y; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan., Marincola FM; Research Branch, Sidra Medical and Research Centre, Doha, Qatar., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione 'G. Pascale', Napoli, Italy., Sargent DJ; Cancer Center Statistics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Fox BA; Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France. Electronic address: jerome.galon@crc.jussieu.fr.
Publikováno v:
Lancet (London, England) [Lancet] 2018 May 26; Vol. 391 (10135), pp. 2128-2139. Date of Electronic Publication: 2018 May 10.